Bottom line
Is CDCRX a good fund? The bottom line
CDCRX is a share class of Copeland Dividend Growth Fund, a managed dividend & equity income mutual fund from Copeland.
It charges 1.95% — about $195 a year on every $10,000 invested, more expensive than 97% of dividend & equity income funds we track.
It returned +7.8% over one year, +8.0% a year over five years, +7.4% a year over ten (as of Dec 31, 2025, per its prospectus).
With $25.8 million in net assets and 65 holdings, its largest position is Lam Research Corp (2.7%) and the top 10 make up 24.1% of the portfolio.
What stands out
- No front-end sales load
What to watch
- Expensive for its category (1.95%)
- 5-year return in the bottom quarter of its category
- 12b-1 marketing fee of 1% a year
- Small fund ($25.8 million) — small funds are likelier to close
Updated Nov 19, 2026
What CDCRX invests in
The Fund seeks long-term capital appreciation and income generation.
The Fund seeks to achieve its investment objectives of producing long-term capital appreciation and income generation by purchasing equities of companies with a proven track record of dividend growth. The Fund is primarily composed of common stocks, master limited partnership units (?MLPs?) and equity real estate investment trusts (?REITs?) of U.S. companies or entities that have raised their dividends in the most recent annual period and cash equivalents. The Fund will limit its investment in MLPs to no more than 25% of its net assets. An equity REIT invests the majority of its assets directly in real property and derives its income primarily from rents and from capital gains on real estate appreciation, which are realized through property sales. Under normal market conditions, the Fund invests at least 80% of its net assets (including borrowings for investment purposes) in securities…
From the fund's prospectus (filed Mar 27, 2026).
CDCRX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| CDCRX | +7.8% | +8.0% | +7.4% |
| Dividend & Equity Income median | +14.6% | +10.1% | +9.2% |
Source: Fund prospectus, as of Dec 31, 2025
What CDCRX costs
On a $10,000 investment, CDCRX's 1.95% expense ratio costs about $195 a year. The prospectus estimates $2,950 in total costs over 10 years (assuming 5% annual returns). The median dividend & equity income fund charges 0.74%.
CDCRX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Lam Research Corp | 2.67% |
| 2 | Broadcom Inc | 2.64% |
| 3 | Apple Inc | 2.63% |
| 4 | Morgan Stanley | 2.45% |
| 5 | Wesco International Inc | 2.36% |
| 6 | Taiwan Semiconductor Manufacturing Company Ltd | 2.34% |
| 7 | J.b. Hunt Transport Services Inc | 2.33% |
| 8 | Alphabet Inc | 2.27% |
| 9 | Microsoft Corp | 2.25% |
| 10 | Amphenol Corp | 2.19% |
Source: SEC Form N-PORT, period ended May 31, 2026
The top 10 make up 24.1% of the fund. See all top 25 holdings and asset mix →